These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 30616601)

  • 21. A Multi-Institutional Analysis of Prostate Cancer Patients With or Without 68Ga-PSMA PET/CT Prior to Salvage Radiotherapy of the Prostatic Fossa.
    Schmidt-Hegemann NS; Zamboglou C; Thamm R; Eze C; Kirste S; Spohn S; Li M; Stief C; Bolenz C; Schultze-Seemann W; Bartenstein P; Prasad V; Ganswindt U; Grosu AL; Belka C; Mayer B; Wiegel T
    Front Oncol; 2021; 11():723536. PubMed ID: 34660290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and Internal Validation of a Novel Nomogram Predicting the Outcome of Salvage Radiation Therapy for Biochemical Recurrence after Radical Prostatectomy in Patients without Metastases on Restaging Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography.
    Meijer D; van Leeuwen PJ; Eppinga WSC; Vanneste BGL; Meijnen P; Daniels LA; van den Bergh RCN; Lont AP; Bodar YJL; Ettema RH; de Bie KCC; Oudshoorn FHK; Nieuwenhuijzen JA; van der Poel HG; Donswijk ML; Heymans MW; Oprea-Lager DE; Schaake EE; Vis AN
    Eur Urol Open Sci; 2024 Mar; 61():37-43. PubMed ID: 38384437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesorectal Lymph Node Metastases as Index Lesion in
    Leitsmann C; Schmid M; Sahlmann CO; Trojan L; Strauss A
    Front Surg; 2021; 8():637134. PubMed ID: 33732729
    [No Abstract]   [Full Text] [Related]  

  • 24.
    Calais J; Ceci F; Eiber M; Hope TA; Hofman MS; Rischpler C; Bach-Gansmo T; Nanni C; Savir-Baruch B; Elashoff D; Grogan T; Dahlbom M; Slavik R; Gartmann J; Nguyen K; Lok V; Jadvar H; Kishan AU; Rettig MB; Reiter RE; Fendler WP; Czernin J
    Lancet Oncol; 2019 Sep; 20(9):1286-1294. PubMed ID: 31375469
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection level and pattern of positive lesions using PSMA PET/CT for staging prior to radiation therapy.
    Schmidt-Hegemann NS; Fendler WP; Buchner A; Stief C; Rogowski P; Niyazi M; Eze C; Li M; Bartenstein P; Belka C; Ganswindt U
    Radiat Oncol; 2017 Nov; 12(1):176. PubMed ID: 29126446
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Sonni I; Dal Pra A; O'Connell DP; Ells Z; Benz M; Nguyen K; Yoon SM; Deng J; Smith C; Grogan T; Nickols NG; Cao M; Kishan AU; Calais J
    J Nucl Med; 2023 Jun; 64(6):902-909. PubMed ID: 36759200
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSA < 0.2 ng/ml.
    Solomonidou N; Germanou D; Strouthos I; Karagiannis E; Farolfi A; Koerber SA; Debus J; Peeken JC; Vogel ME; Vrachimis A; Spohn SKB; Shelan M; Aebersold D; Grosu AL; Ceci F; Kroeze SGC; Guckenberger M; Fanti S; Belka C; Hruby G; Scharl S; Wiegel T; Bartenstein P; Henkenberens C; Emmett L; Schmidt-Hegemann NS; Ferentinos K; Zamboglou C
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2529-2536. PubMed ID: 36905411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pattern of Prostate Cancer Recurrence Assessed by
    Lawal IO; Lengana T; Popoola GO; Orunmuyi AT; Kgatle MM; Mokoala KMG; Sathekge MM
    J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Outcome after PSMA PET/CT based salvage radiotherapy in patients with biochemical recurrence after radical prostatectomy: a bi-institutional retrospective analysis.
    Schmidt-Hegemann NS; Stief C; Kim TH; Eze C; Kirste S; Strouthos I; Li M; Schultze-Seemann W; Ilhan H; Fendler WP; Bartenstein P; Grosu AL; Ganswindt U; Belka C; Meyer PT; Zamboglou C
    J Nucl Med; 2019 Feb; 60(2):227-233. PubMed ID: 30002108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of 18 F-Fluciclovine PET/CT Findings on Failure-Free Survival in Biochemical Recurrence of Prostate Cancer Following Salvage Radiation Therapy.
    Lawal IO; Marcus C; Schuster DM; Goyal S; Adediran OA; Dhere VR; Joshi SS; Abiodun-Ojo OA; Master VA; Patel PR; Fielder B; Goodman M; Shelton JW; Kucuk O; Hershatter B; Halkar RK; Jani AB
    Clin Nucl Med; 2023 Apr; 48(4):e153-e159. PubMed ID: 36754362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of relapse as determined by
    Henkenberens C; Derlin T; Bengel FM; Ross TL; Wester HJ; Hueper K; Kuczyk MA; Christiansen H; von Klot CA
    Strahlenther Onkol; 2018 Apr; 194(4):303-310. PubMed ID: 29134231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Failure Patterns by PSMA PET for Recurrent Prostate Cancer after Prostatectomy and Salvage Radiation.
    Imber BS; O'Dwyer E; Lobaugh S; McBride SM; Hopkins M; Kollmeier M; Gorovets D; Brennan V; Pike LRG; Gewanter R; Mychalczak B; Zhang Z; Schöder H; Zelefsky MJ
    Urology; 2022 Dec; 170():146-153. PubMed ID: 36115426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PSMA guided approach for bIoCHEmical relapse after prostatectomy- (PSICHE) trial (NCT05022914). Detection rate and treatment decision after 68Ga-PSMA PET/CT within a prospective study.
    Francolini G; Banini M; Di Cataldo V; Detti B; Caini S; Loi M; Simontacchi G; Desideri I; Greto D; Valzano M; Roghi M; Serni S; Vaggelli L; Salvestrini V; Visani L; Becherini C; Olmetto E; Franzese C; Baldaccini D; Scorsetti M; Sollini M; Chiti A; Meattini I; Valicenti RK; Livi L
    Prostate; 2023 Sep; 83(12):1201-1206. PubMed ID: 37290915
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prospective phase II study of prostate-specific antigen-guided salvage radiotherapy and
    Gunnlaugsson A; Johannesson V; Wieslander E; Brun E; Bitzen U; Ståhl O; Bratt O; Ahlgren G; Ohlsson T; Kjellén E; Nilsson P
    Clin Transl Radiat Oncol; 2022 Sep; 36():77-82. PubMed ID: 35873652
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of gallium-68 prostate-specific membrane antigen positron-emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature.
    Luiting HB; van Leeuwen PJ; Busstra MB; Brabander T; van der Poel HG; Donswijk ML; Vis AN; Emmett L; Stricker PD; Roobol MJ
    BJU Int; 2020 Feb; 125(2):206-214. PubMed ID: 31680398
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    Deandreis D; Guarneri A; Ceci F; Lillaz B; Bartoncini S; Oderda M; Nicolotti DG; Pilati E; Passera R; Zitella A; Bellò M; Parise R; Carlevato R; Ricardi U; Gontero P
    Eur J Nucl Med Mol Imaging; 2020 Nov; 47(12):2804-2815. PubMed ID: 32314028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can
    Khanna Y; Chinni V; Gnanasambantham K; O'Sullivan R; Ballok ZE; Ryan A; Ramdave S; Sivaratnam D; Bowden P; Guerrieri M; Ranasinghe WKB; Frydenberg M
    BJU Int; 2023 Sep; 132(3):321-328. PubMed ID: 37190993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (68) Ga-PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment.
    van Leeuwen PJ; Stricker P; Hruby G; Kneebone A; Ting F; Thompson B; Nguyen Q; Ho B; Emmett L
    BJU Int; 2016 May; 117(5):732-9. PubMed ID: 26683282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PEACE V - Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): a study protocol for a randomized controlled phase II trial.
    De Bruycker A; Spiessens A; Dirix P; Koutsouvelis N; Semac I; Liefhooghe N; Gomez-Iturriaga A; Everaerts W; Otte F; Papachristofilou A; Scorsetti M; Shelan M; Siva S; Ameye F; Guckenberger M; Heikkilä R; Putora PM; Zapatero A; Conde-Moreno A; Couñago F; Vanhoutte F; Goetghebeur E; Reynders D; Zilli T; Ost P
    BMC Cancer; 2020 May; 20(1):406. PubMed ID: 32398040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A phase II randomized placebo-controlled double-blind study of salvage radiation therapy plus placebo versus SRT plus enzalutamide with high-risk PSA-recurrent prostate cancer after radical prostatectomy (SALV-ENZA).
    Kapoor R; Deek MP; McIntyre R; Raman N; Kummerlowe M; Chen I; Gaver M; Wang H; Denmeade S; Lotan T; Paller C; Markowski M; Carducci M; Eisenberger M; Beer TM; Song DY; DeWeese TL; Hearn JW; Greco S; DeVille C; Desai NB; Heath EI; Liauw S; Spratt DE; Hung AY; Antonarakis ES; Tran PT
    BMC Cancer; 2019 Jun; 19(1):572. PubMed ID: 31196032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.